American journal of translational research · 2021
Effect of a low temperature plasma knife on the treatment of chronic tonsillitis and its effect on T lymphocyte subsets.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Fei
Аннотация
OBJECTIVE: To investigate the effect of a low temperature plasma knife on the treatment of chronic tonsillitis and its effect on T lymphocyte subsets.
METHODS: A total of 70 patients diagnosed with tonsillitis from March 2017 to October 2018 were selected as research subjects. Among them, patients treated by routine surgery were placed into the control group (33 cases), and patients treated by low temperature plasma knife were placed in the observation group (37 cases). The clinical efficacy, intraoperative blood loss, operative time, time of complete white membrane coverage, time of complete white membrane shedding, pain scoring, adverse reactions and the influence on T cell subsets between the two groups were compared.
RESULTS: The clinical treatment efficacy of the observation group was significantly higher than that of the control group (P<0.05). The operative time, intraoperative blood loss, time of complete white membrane coverage and time of complete white membrane shedding in the observation group were significantly lower than those in the control group. The pain score of patients in the observation group was significantly lower than in the control group on 1 d, 3 d and 5 d after surgery (P<0.05), while there was no significant difference in pain score between the two groups 7 d after surgery (P>0.05). There was no significant difference between the observation group and the control group in postoperative blood loss, torus tubarius injury and adverse nasal adhesion (P>0.05). The total curative effective rate of the control group was significantly lower than that of the observation group (P<0.05).
CONCLUSION: To sum up, a low temperature plasma knife has good effects in the treatment of chronic tonsillitis, which can alleviate the pain response of patients without increasing the incidence of adverse reactions, and as such it is worthy of clinical promotion.
METHODS: A total of 70 patients diagnosed with tonsillitis from March 2017 to October 2018 were selected as research subjects. Among them, patients treated by routine surgery were placed into the control group (33 cases), and patients treated by low temperature plasma knife were placed in the observation group (37 cases). The clinical efficacy, intraoperative blood loss, operative time, time of complete white membrane coverage, time of complete white membrane shedding, pain scoring, adverse reactions and the influence on T cell subsets between the two groups were compared.
RESULTS: The clinical treatment efficacy of the observation group was significantly higher than that of the control group (P<0.05). The operative time, intraoperative blood loss, time of complete white membrane coverage and time of complete white membrane shedding in the observation group were significantly lower than those in the control group. The pain score of patients in the observation group was significantly lower than in the control group on 1 d, 3 d and 5 d after surgery (P<0.05), while there was no significant difference in pain score between the two groups 7 d after surgery (P>0.05). There was no significant difference between the observation group and the control group in postoperative blood loss, torus tubarius injury and adverse nasal adhesion (P>0.05). The total curative effective rate of the control group was significantly lower than that of the observation group (P<0.05).
CONCLUSION: To sum up, a low temperature plasma knife has good effects in the treatment of chronic tonsillitis, which can alleviate the pain response of patients without increasing the incidence of adverse reactions, and as such it is worthy of clinical promotion.